US6764697B1
(en)
*
|
1991-06-27 |
2004-07-20 |
Alza Corporation |
System for delaying drug delivery up to seven hours
|
US5160744A
(en)
*
|
1991-06-27 |
1992-11-03 |
Alza Corporation |
Verapmil therapy
|
GB9117361D0
(en)
*
|
1991-08-12 |
1991-09-25 |
Euro Celtique Sa |
Oral dosage form
|
FI93924C
(fi)
*
|
1991-09-17 |
1995-06-26 |
Martti Lauri Antero Marvola |
Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
|
US5422122A
(en)
*
|
1992-08-04 |
1995-06-06 |
Eurand America, Incorporated |
Controlled release potassium chloride tablet
|
DE69332081T2
(de)
*
|
1992-09-18 |
2003-02-06 |
Yamanouchi Pharmaceutical Co., Ltd. |
Hydrogelzubereitung mit verzögerter freisetzung
|
EP0621032B1
(fr)
*
|
1993-04-23 |
2000-08-09 |
Novartis AG |
Dispositif d'administration de médicaments à libération contrôlée
|
US6440457B1
(en)
*
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
US5922736A
(en)
*
|
1995-12-04 |
1999-07-13 |
Celegene Corporation |
Chronic, bolus administration of D-threo methylphenidate
|
US5837284A
(en)
*
|
1995-12-04 |
1998-11-17 |
Mehta; Atul M. |
Delivery of multiple doses of medications
|
US6486177B2
(en)
*
|
1995-12-04 |
2002-11-26 |
Celgene Corporation |
Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
|
US6096339A
(en)
*
|
1997-04-04 |
2000-08-01 |
Alza Corporation |
Dosage form, process of making and using same
|
US6919373B1
(en)
*
|
1996-11-12 |
2005-07-19 |
Alza Corporation |
Methods and devices for providing prolonged drug therapy
|
EP0946151B1
(fr)
*
|
1996-11-25 |
2006-05-10 |
Alza Corporation |
Forme posologique a doses croissantes
|
EP1782798A3
(fr)
|
1996-11-25 |
2008-05-21 |
Alza Corporation |
Forme posologique à libération de dose croissante
|
US5788987A
(en)
|
1997-01-29 |
1998-08-04 |
Poli Industria Chimica Spa |
Methods for treating early morning pathologies
|
IT1291652B1
(it)
*
|
1997-04-24 |
1999-01-19 |
Apr Trading Sa |
Composizioni farmaceutiche a copertura terapeutica programmata
|
US6962997B1
(en)
*
|
1997-05-22 |
2005-11-08 |
Celgene Corporation |
Process and intermediates for resolving piperidyl acetamide steroisomers
|
DE19747261A1
(de)
*
|
1997-10-25 |
1999-04-29 |
Bayer Ag |
Osmotisches Arzneimittelfreisetzungssystem
|
US8524277B2
(en)
|
1998-03-06 |
2013-09-03 |
Alza Corporation |
Extended release dosage form
|
US5945123A
(en)
*
|
1998-04-02 |
1999-08-31 |
K-V Pharmaceutical Company |
Maximizing effectiveness of substances used to improve health and well being
|
KR100827254B1
(ko)
*
|
1998-06-03 |
2008-05-07 |
알자 코포레이션 |
연장된 약물 치료를 제공하기 위한 방법 및 장치
|
US6524620B2
(en)
|
1998-07-20 |
2003-02-25 |
Andrx Pharmaceuticals, Inc. |
Diltiazem controlled release formulation and method of manufacture
|
JP2002521347A
(ja)
*
|
1998-07-21 |
2002-07-16 |
アルペンストック・ホールディングス・リミテッド |
陰イオン多糖を含む徐放製剤
|
US6322819B1
(en)
|
1998-10-21 |
2001-11-27 |
Shire Laboratories, Inc. |
Oral pulsed dose drug delivery system
|
EP1126826B3
(fr)
|
1998-11-02 |
2019-05-15 |
Alkermes Pharma Ireland Limited |
Composition de methylphenidate a liberation modifiee multiparticulaire
|
US6419960B1
(en)
|
1998-12-17 |
2002-07-16 |
Euro-Celtique S.A. |
Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
|
US6387403B1
(en)
|
1999-09-15 |
2002-05-14 |
Alza Corporation |
Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing
|
US6610674B1
(en)
*
|
1999-09-28 |
2003-08-26 |
University Of Pennsylvania |
Method of treating inflammatory conditions with progesterone analogs
|
EP1227798A4
(fr)
|
1999-10-29 |
2004-06-30 |
Euro Celtique Sa |
Formulations d'hydrocodone a liberation lente
|
US20060153914A1
(en)
*
|
1999-12-10 |
2006-07-13 |
Biovail Laboratories International S.R.L. |
Chronotherapeutic diltiazem formulations and the administration thereof
|
US7108866B1
(en)
|
1999-12-10 |
2006-09-19 |
Biovall Laboratories International Srl |
Chronotherapeutic diltiazem formulations and the administration thereof
|
BR0016707A
(pt)
|
1999-12-23 |
2002-09-03 |
Pfizer Prod Inc |
Forma de dosagem de droga em camadas acionada por hidrogel
|
DZ3228A1
(fr)
*
|
1999-12-23 |
2001-07-05 |
Pfizer Prod Inc |
Médicament dérivé d'un hydrogel sous forme de pastille
|
US7732404B2
(en)
|
1999-12-30 |
2010-06-08 |
Dexcel Ltd |
Pro-nanodispersion for the delivery of cyclosporin
|
KR100960200B1
(ko)
|
2000-10-30 |
2010-05-27 |
유로-셀티크 소시에떼 아노뉨 |
서방성 하이드로코돈 제형
|
US20110104214A1
(en)
|
2004-04-15 |
2011-05-05 |
Purdue Pharma L.P. |
Once-a-day oxycodone formulations
|
AU2002320360B2
(en)
*
|
2001-07-10 |
2005-05-26 |
Teva Pharmaceutical Industries Ltd. |
Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery
|
US6863901B2
(en)
*
|
2001-11-30 |
2005-03-08 |
Collegium Pharmaceutical, Inc. |
Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
|
US6827946B2
(en)
*
|
2001-12-05 |
2004-12-07 |
Collegium Pharmaceutical, Inc. |
Compositions containing both sedative and non-sedative antihistamines
|
US20030125714A1
(en)
*
|
2001-12-18 |
2003-07-03 |
Edgren David Emil |
Dosage form for time-varying patterns of drug delivery
|
US20040052843A1
(en)
*
|
2001-12-24 |
2004-03-18 |
Lerner E. Itzhak |
Controlled release dosage forms
|
BR0215413A
(pt)
*
|
2001-12-24 |
2004-12-14 |
Teva Pharma |
Formula dosada com um comprimido central de ingrediente ativo encapado em uma capa anular prensada de material em pó ou granulado e processo e conjunto de ferramentas para a sua produção
|
US20050106249A1
(en)
*
|
2002-04-29 |
2005-05-19 |
Stephen Hwang |
Once-a-day, oral, controlled-release, oxycodone dosage forms
|
MXPA04010769A
(es)
*
|
2002-04-29 |
2005-07-05 |
Alza Corp |
Metodos y formas de dosificacion para suministro controlado de oxicodona.
|
MXPA04012021A
(es)
*
|
2002-05-31 |
2005-08-16 |
Johnson & Johnson |
Formas de dosis y composiciones para la administracion osmotica de dosis variables de oxicodona.
|
AR039744A1
(es)
*
|
2002-06-26 |
2005-03-09 |
Alza Corp |
Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
|
US20040005359A1
(en)
*
|
2002-06-27 |
2004-01-08 |
Cheng Xiu Xiu |
Controlled release oral dosage form
|
US20050208132A1
(en)
*
|
2002-07-29 |
2005-09-22 |
Gayatri Sathyan |
Methods and dosage forms for reducing side effects of benzisozazole derivatives
|
US20050232995A1
(en)
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
PT1539115E
(pt)
*
|
2002-07-29 |
2008-01-14 |
Alza Corp |
Métodos e formas de dosagem para libertação controlada de paliperidona
|
WO2004010970A1
(fr)
*
|
2002-07-29 |
2004-02-05 |
Alza Corporation |
Formulations et formes posologiques pour une administration controlee de topiramate
|
WO2004012705A1
(fr)
*
|
2002-07-31 |
2004-02-12 |
Phafag Ag |
Formulation pharmaceutique et son utilisation dans le traitement des maladies de l'oreille interne
|
US6913768B2
(en)
*
|
2002-09-24 |
2005-07-05 |
Shire Laboratories, Inc. |
Sustained release delivery of amphetamine salts
|
CA2507522C
(fr)
|
2002-12-13 |
2015-02-24 |
Durect Corporation |
Systeme d'administration de medicaments par voie orale
|
US20070077301A1
(en)
*
|
2002-12-23 |
2007-04-05 |
Meyer Glenn A |
Venlafaxine osmotic device formulation
|
US8293799B2
(en)
*
|
2003-12-29 |
2012-10-23 |
Osmotica Keresleedelmo és Szolgáltató KFT |
Osmotic device containing a venlafaxine salt and a salt having an ion in common
|
US20040166160A1
(en)
*
|
2003-01-14 |
2004-08-26 |
Ramkumar Subramanian |
Methods and dosage forms with modified viscosity layers
|
WO2004071497A1
(fr)
*
|
2003-02-11 |
2004-08-26 |
Alza Corporation |
Methodes et formes dosifiees presentant une geometrie de couche modifiee
|
US7632521B2
(en)
*
|
2003-07-15 |
2009-12-15 |
Eurand, Inc. |
Controlled release potassium chloride tablets
|
EP1653922A2
(fr)
*
|
2003-08-06 |
2006-05-10 |
Alza Corporation |
Administration reguliere de topiramate pendant une periode prolongee a formulation de dispersion amelioree
|
CA2536507A1
(fr)
*
|
2003-08-22 |
2005-03-10 |
Alza Corporation |
Administration progressive de topiramate sur une duree prolongee
|
CA2564227A1
(fr)
*
|
2003-09-02 |
2005-03-10 |
Alza Corporation |
Compositions medicamenteuses et formes pharmaceutiques de topiramate
|
AU2004275816A1
(en)
*
|
2003-09-26 |
2005-04-07 |
Alza Corporation |
Controlled release formulations of opioid and nonopioid analgesics
|
JP4919801B2
(ja)
|
2003-09-26 |
2012-04-18 |
アルザ・コーポレーシヨン |
高い薬剤配合量を提供する薬剤コーティング及びそれを提供する方法
|
US20050260268A1
(en)
*
|
2003-09-26 |
2005-11-24 |
Modi Nishit B |
Methods and dosage forms for controlled delivery of alprazolam
|
WO2005030182A1
(fr)
|
2003-09-26 |
2005-04-07 |
Alza Corporation |
Formulations a liberation commandee presentant un taux croisssant de liberation
|
AU2004285532A1
(en)
*
|
2003-10-31 |
2005-05-12 |
Alza Corporation |
Administration of levodopa and carbidopa
|
CN1905856A
(zh)
*
|
2003-12-23 |
2007-01-31 |
阿尔扎公司 |
用于增加受控递送的药物组合物的溶解度的方法和剂型
|
US20050175696A1
(en)
*
|
2003-12-29 |
2005-08-11 |
David Edgren |
Drug granule coatings that impart smear resistance during mechanical compression
|
MXPA06007510A
(es)
*
|
2003-12-29 |
2009-06-10 |
Johnson & Johnson |
Composiciones de farmaco y formas de dosis novedosas de topiramato.
|
MXPA06007509A
(es)
*
|
2003-12-29 |
2007-10-18 |
Johnson & Johnson |
Composiciones de farmaco y formas de dosis novedosas.
|
US20050239830A1
(en)
*
|
2004-04-26 |
2005-10-27 |
Vikram Khetani |
Methods of diminishing co-abuse potential
|
US20050287213A1
(en)
*
|
2004-06-28 |
2005-12-29 |
Wong Patrick S |
Dosage forms for low solubility and or low dissolution rate free acid pharmaceutical agents
|
US8541026B2
(en)
*
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
AR053986A1
(es)
|
2004-12-03 |
2007-05-30 |
Osmotica Pharmaceutical Argent |
Dispositivo osmotico que contiene amantadina y una sal osmotica
|
AU2005313887B2
(en)
*
|
2004-12-09 |
2011-10-27 |
Celgene Corporation |
Treatment using D-threo methylphenidate
|
WO2006081569A2
(fr)
*
|
2005-01-27 |
2006-08-03 |
Alza Corporation |
Forme galenique osmotique orale comprenant une membrane a flux eleve
|
WO2006113568A2
(fr)
*
|
2005-04-19 |
2006-10-26 |
Alza Corporation |
Combinaison de tramadol et de matieres renfermant la gabapentine
|
WO2007002872A2
(fr)
*
|
2005-06-29 |
2007-01-04 |
Alza Corporation |
Compositions semi-permeables permettant de reduire le temps de sechage de formes posologiques osmotiques
|
WO2007106111A2
(fr)
*
|
2005-07-01 |
2007-09-20 |
Elan Pharma International Limited |
Compositions nanoparticulaires et a liberation controlee comprenant de la nilvadipine
|
WO2007019393A2
(fr)
*
|
2005-08-04 |
2007-02-15 |
Alza Corporation |
Formes posologiques osmotiques comprenant des membranes semi-permeables formees de melanges polymeres presentant des caracteristiques ameliorees
|
US8778395B2
(en)
*
|
2005-08-11 |
2014-07-15 |
Andrx Labs, Llc |
Diltiazem controlled release formulation and method of manufacture
|
WO2007044234A1
(fr)
*
|
2005-10-07 |
2007-04-19 |
Alza Corporation |
Forme posologique osmotique a aspects de liberation controlee et de liberation rapide
|
PL116330U1
(en)
*
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
US20070196487A1
(en)
*
|
2006-02-16 |
2007-08-23 |
Geerke Johan H |
Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
|
CN102488652B
(zh)
|
2006-03-16 |
2014-06-18 |
特瑞斯制药股份有限公司 |
含有药物-离子交换树脂复合物的经修饰释放的制剂
|
TW200815045A
(en)
*
|
2006-06-29 |
2008-04-01 |
Jazz Pharmaceuticals Inc |
Pharmaceutical compositions of ropinirole and methods of use thereof
|
WO2008021875A2
(fr)
*
|
2006-08-08 |
2008-02-21 |
Accu-Break Technologies, Inc. |
Comprimé pharmaceutique contenant une pluralité de segments actifs
|
EP2119442A4
(fr)
|
2006-12-28 |
2010-12-15 |
Astellas Pharma Inc |
Composition pharmaceutique à libération entretenue de tacrolimus
|
US8524749B2
(en)
*
|
2007-02-09 |
2013-09-03 |
Alza Corporation |
Controlled release compositions of tizanidine
|
WO2008105920A1
(fr)
*
|
2007-02-28 |
2008-09-04 |
Collegium Pharmaceutical, Inc. |
Combinaison d'antihistaminiques
|
JP2011506318A
(ja)
|
2007-12-06 |
2011-03-03 |
デュレクト コーポレーション |
経口医薬製剤
|
JP2011511782A
(ja)
|
2008-02-12 |
2011-04-14 |
アボット・ラボラトリーズ |
長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
|
WO2009137827A2
(fr)
*
|
2008-05-09 |
2009-11-12 |
Tiara Pharmaceuticals, Inc. |
Libération contrôlée de n-acétylcystéine (nac) en vue de la réduction de l'inflammation systémique et/ou vasculaire
|
MX2011000909A
(es)
*
|
2008-07-30 |
2011-02-23 |
Panacea Biotec Ltd |
Composiciones de ramipril de liberacion modificada y usos de las mismas.
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
WO2010077925A2
(fr)
|
2008-12-16 |
2010-07-08 |
Teva Pharmaceutical Industries Ltd. |
Système d'administration médicamenteuse d'ordre zéro, administration médicamenteuse biphasique d'ordre zéro, ascendante ou descendante de méthylphénidate
|
US8568793B2
(en)
*
|
2009-02-11 |
2013-10-29 |
Hope Medical Enterprises, Inc. |
Sodium nitrite-containing pharmaceutical compositions
|
US9005661B2
(en)
|
2009-09-15 |
2015-04-14 |
Beijing Team Hospital Management Co., Ltd. |
Osmotic pump controlled release tablet and preparation method thereof
|
CA2789307A1
(fr)
*
|
2010-03-29 |
2011-10-06 |
Hetero Research Foundation |
Composition pharmaceutique stable d'imatinib
|
EP2554168B1
(fr)
|
2010-03-29 |
2018-01-24 |
Astellas Pharma Inc. |
Composition pharmaceutique à libération contrôlée
|
US8287903B2
(en)
|
2011-02-15 |
2012-10-16 |
Tris Pharma Inc |
Orally effective methylphenidate extended release powder and aqueous suspension product
|
MX358059B
(es)
*
|
2012-01-17 |
2018-08-03 |
Croda Inc |
Aditivo de hinchamiento de sellos.
|
EP2884961B1
(fr)
|
2012-08-15 |
2019-03-06 |
Tris Pharma Inc. |
Comprimé à croquer de méthylphénidate à libération modifiée
|
CN105120659A
(zh)
|
2013-03-15 |
2015-12-02 |
度瑞公司 |
用于降低溶解可变性的具有流变改性剂的组合物
|
CA2936740C
(fr)
|
2014-10-31 |
2017-10-10 |
Purdue Pharma |
Methodes et compositions destinees au traitement du trouble de deficit d'attention
|
US11590228B1
(en)
|
2015-09-08 |
2023-02-28 |
Tris Pharma, Inc |
Extended release amphetamine compositions
|
JP7258561B2
(ja)
|
2016-07-06 |
2023-04-17 |
オリエント ファーマ シーオー.,エルティーディー. |
薬物組成物、バリヤー層及び薬物層を有している経口投与形態
|
US9707217B1
(en)
|
2017-02-03 |
2017-07-18 |
Osmotica Kereskedelmi Es Szolgaltato Kft |
Dose-dumping resistant controlled release dosage form
|
US11590081B1
(en)
|
2017-09-24 |
2023-02-28 |
Tris Pharma, Inc |
Extended release amphetamine tablets
|
SG11202007825XA
(en)
|
2018-02-16 |
2020-09-29 |
Esperion Therapeutics Inc |
Sustained release formulations of bempedoic acid
|
JP7195345B2
(ja)
*
|
2018-03-05 |
2022-12-23 |
アムニール コンプレックス プロダクツ リサーチ エルエルシー |
薬物の時間放出のためのプログラム可能な医薬組成物
|
US10722473B2
(en)
|
2018-11-19 |
2020-07-28 |
Purdue Pharma L.P. |
Methods and compositions particularly for treatment of attention deficit disorder
|
US11547670B2
(en)
|
2019-03-05 |
2023-01-10 |
Amneal Complex Products Research Llc |
Delayed release methylphenidate compositions
|
BR112022001645A2
(pt)
|
2019-08-12 |
2022-05-03 |
Massachusetts Inst Technology |
Artigo configurado para liberação de um agente terapêutico, e, métodos para distribuir fármaco intestinal e para administrar um agente terapêutico
|
CN114681422B
(zh)
*
|
2020-12-30 |
2023-09-05 |
深圳翰宇药业股份有限公司 |
一种硝苯地平控释片及其制备方法
|